Karlyssa Chung, MSPAS, PA-C
Assistant Professor of Physician Assistant Studies
Director of Clinical Education, Physician Assistant Studies
Physician Assistant
Office Phone: 951-552-8344
E-mail: kachung@calbaptist.edu
Degree | Major Emphasis | Institution | Year |
---|---|---|---|
MSPAS, PA-C | Master of Physician Assistant Studies | Western University of Health Sciences | 2012 |
B.A. | Bachelor of Art in Human Development | University of California, San Diego | 2007 |
Beginning my PA career in the field of family medicine, I honed my skills in primary care, navigating the diverse landscape of patient needs across the lifespan. The lateral mobility inherent in the PA profession paved the way for a new calling and an unexpected opportunity in neurosurgery—a specialty I never imagined myself in, but one that sparked a newfound passion within me.
In 2020, my journey as an educator seamlessly intertwined with my PA career as I assumed the role of full-time faculty in the PA Studies Department at CBU. Witnessing both of my undergraduate aspirations materialize—serving as both an educator and a medical provider—has been an immense blessing. As the director of clinical education for the CBU PA studies program, I have embraced the opportunity to help guide the next generation of PAs, embodying generative concern and paving the way for their professional growth. Collaborating with esteemed PA faculty and staff, I take pride in mentoring and educating our students to embody professionalism, ethics, sensitivity, compassion, and selflessness.
Currently enrolled as a doctoral student in the EdD for Health Professions Education program at A.T. Still University
Injection of Autologous Adipose Derived Stromal Vascular Fraction (ADSVF) Into the Human Brain Ventricular System for Neurodegenerative Disorders, INTERNATIONAL SOCIETY OF CELLULAR THERAPY (ISCT) 2016
Human intracerebroventricular (ICV) injection of autologous non-engineered, adipose-derived stromal vascular fraction (ADSVF) for neurodegenerative disorders: results of a 3-year phase 1 study of 113 injections in 31 patients. MOLECULAR BIOLOGY REPORTS (2019)
Calvary Church
The greatest legacy we can leave is not in what we achieve, but in how we empower others to continue the work and meaningful contributions.